Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Ingmar Wolff"'
Autor:
Maryna Somova, Stefan Simm, Adventina Padmyastuti, Jens Ehrhardt, Janosch Schoon, Ingmar Wolff, Martin Burchardt, Cindy Roennau, Pedro Caetano Pinto
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract The advent of micro-physiological systems (MPS) in biomedical research has enabled the introduction of more complex and relevant physiological into in vitro models. The recreation of complex morphological features in three-dimensional enviro
Externí odkaz:
https://doaj.org/article/c85c73dc57cb4e478f2a492b1044af8f
Publikováno v:
Cancer Medicine, Vol 13, Iss 15, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/80d800fd50f4483cbb61b597bd3b5416
Publikováno v:
Technology Innovation Management Review, Vol 11, Iss 3, Pp 17-31 (2021)
Startups searching for a business model face uncertainty. This research aims to demonstrates how B2B startups can use business experiments to discover and validate their business model's desirability quickly and cost-effectively. The research study f
Externí odkaz:
https://doaj.org/article/27aa2d9f88244401b8c32adc409386a8
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/90ab6bba669a4daf860e854f8ecaa9a0
Publikováno v:
Biomedicines, Vol 9, Iss 12, p 1761 (2021)
Kidney cancer and chronic kidney disease are two renal pathologies with very different clinical management strategies and therapeutical options. Nonetheless, the cellular and molecular mechanisms underlying both conditions are closely related. Renal
Externí odkaz:
https://doaj.org/article/abd5104be4ad44fa89d0420691ac32b1
Autor:
Nina Wagener, Dominic Edelmann, Axel Benner, Richard Zigeuner, Hendrik Borgmann, Ingmar Wolff, Laura M Krabbe, Mireia Musquera, Paolo Dell'Oglio, Umberto Capitanio, Tobias Klatte, Luca Cindolo, Matthias May, Sabine D Brookman-May, European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184173 (2017)
Renal cell carcinoma (RCC) comprises a heterogenous group of tumors. Traditionally, papillary RCC (pRCC) is associated with a favorable outcome compared to clear cell RCC (ccRCC), while other series report equivalent or worse prognosis. In this paper
Externí odkaz:
https://doaj.org/article/5784d460830f49f7b457e739b82c5081
Autor:
Juana Dornbusch, Aristeidis Zacharis, Matthias Meinhardt, Kati Erdmann, Ingmar Wolff, Michael Froehner, Manfred P Wirth, Stefan Zastrow, Susanne Fuessel
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e76386 (2013)
Patients with metastatic clear cell renal cell carcinoma (ccRCC) are frequently treated with tyrosine kinase inhibitors (TKI) such as sunitinib. It inhibits angiogenic pathways by mainly targeting the receptors of VEGF and PDGF. In ccRCC, angiogenesi
Externí odkaz:
https://doaj.org/article/3814aabd86094927a018549fd01ac5a5
Autor:
Hellmuth A Meyer, Tobias Endermann, Carsten Stephan, Mette Stoedter, Thomas Behrends, Ingmar Wolff, Klaus Jung, Lutz Schomburg
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46644 (2012)
Selenium (Se) is an essential trace element for selenoprotein biosynthesis. Selenoproteins have been implicated in cancer risk and tumor development. Selenoprotein P (SePP) serves as the major Se transport protein in blood and as reliable biomarker o
Externí odkaz:
https://doaj.org/article/a6d101e1e646478da136bc174c12b2d0
Publikováno v:
Asian Journal of Andrology, Vol 16, Iss 4, Pp 652-653 (2014)
Externí odkaz:
https://doaj.org/article/4f29c1141dec4e669a8ceebf3114ff1f
Publikováno v:
Therapeutic Advances in Urology, Vol 2 (2010)
The treatment of advanced renal cell carcinoma has been completely changed by the development of new therapeutic modalities during the past 3 years. In this time period six targeted agents have been approved for the treatment of advanced or metastati
Externí odkaz:
https://doaj.org/article/0ec09f7631b94be6a853b8d7b7db8a8c